Format

Send to

Choose Destination
See comment in PubMed Commons below
Medicine (Baltimore). 2016 Sep;95(37):e4848. doi: 10.1097/MD.0000000000004848.

In vivo neurometabolic profiling in orthostatic tremor.

Author information

1
aDepartment of Neurology, University Hospital "12 de Octubre" bCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) cDepartment of Medicine, Complutense University, Madrid, Spain dDepartment of Neurology, Yale School of Medicine eDepartment of Chronic Disease Epidemiology, Yale School of Public Health fCenter for Neuroepidemiology and Clinical Neurological Research, Yale School of Medicine and Yale School of Public Health, New Haven, CT gNeuroimaging Laboratory, Center for Biomedical Technology, Rey Juan Carlos University, Madrid, Spain hSchool of Health Sciences, Purdue University, West Lafayette iDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN jDepartment of Radiology, International Ruber Hospital kFaculty of Biosanitary Sciences, Francisco de Vitoria University, Pozuelo de Alarcón, Madrid, Spain lResearch Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA mHM CINAC, HM Hospitales, Madrid, Spain.

Abstract

The pathogenesis of orthostatic tremor (OT) remains unclear, although some evidence points to dysfunction in the brainstem or cerebellum. We used single voxel proton magnetic resonance spectroscopy (1H-MRS) (3 T) to investigate whether neurochemical changes underlie abnormal cerebellar or cortical function in OT. Fourteen OT patients and 14 healthy controls underwent 1H-MRS studies with voxels placed in midparietal gray matter and cerebellum (vermis and central white matter). Spectral analysis was analyzed using the software package LCModel (version 6.3). The absolute metabolite concentrations and ratios of total N-acetylaspartate + N-acetylaspartyl glutamate (NAA), choline-containing compounds, myoinositol, and glutamate + glutamine to creatine were calculated. In midparietal gray matter spectra, we found a significant decrease in the absolute concentration of NAA in OT patients versus healthy controls (7.76 ± 0.25 vs 8.11 ± 0.45, P = 0.017). A similar decrease in NAA was seen in the cerebellar vermis (7.33 ± 0.61 vs 8.55 ± 1.54, P = 0.014) and cerebellar white matter (8.54 ± 0.79 vs 9.95 ± 1.57, P = 0.010). No differences in the other metabolites or their ratios were observed. Reductions in both cerebral cortical and cerebellar NAA suggest that there is neuronal damage or loss in OT, raising the intriguing question as to whether OT is a neurodegenerative disease. Along with clinical history and electrophysio0logical examination, 1H-MRS could serve as a useful diagnostic aid for OT.

PMID:
27631243
PMCID:
PMC5402586
DOI:
10.1097/MD.0000000000004848
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Support Center